Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasmine Thomas

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
ANZ Journal of Surgery|July 1, 2026
Operating Theatre Waste Generation and Segregation in a Tertiary Hospital: A Prospective Waste AuditNicholas McCabe, Nicholas Clarnette, Kaiwen Cabbabe, et al.
Molecules (Basel, Switzerland)|July 2, 2021
Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor ModelRicardo G Alvim, Petrina Georgala, Lucas Nogueira, et al.
Nature Communications|December 20, 2025
Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancerZiyu Chen, Xinran Tang, Jordan E Eichholz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2023
Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric CancerSteven B Maron, Walid Chatila, Henry Walch, et al.
Nature Communications|December 23, 2022
Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiationJoshua I Warrick, Wenhuo Hu, Hironobu Yamashita, et al.
Nature Communications|November 3, 2022
FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiationJoshua I Warrick, Wenhuo Hu, Hironobu Yamashita, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
ANZ Journal of Surgery|July 1, 2026
Operating Theatre Waste Generation and Segregation in a Tertiary Hospital: A Prospective Waste AuditNicholas McCabe, Nicholas Clarnette, Kaiwen Cabbabe, et al.
Molecules (Basel, Switzerland)|July 2, 2021
Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor ModelRicardo G Alvim, Petrina Georgala, Lucas Nogueira, et al.
Nature Communications|December 20, 2025
Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancerZiyu Chen, Xinran Tang, Jordan E Eichholz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2023
Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric CancerSteven B Maron, Walid Chatila, Henry Walch, et al.
Nature Communications|December 23, 2022
Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiationJoshua I Warrick, Wenhuo Hu, Hironobu Yamashita, et al.
Nature Communications|November 3, 2022
FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiationJoshua I Warrick, Wenhuo Hu, Hironobu Yamashita, et al.
Pageof 2